Rumeysa Özyurt

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineMajor global burdens of diseaseInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer.

|Dec 28, 2023
Targeting of Notch, IL-1, and leptin has therapeutic potential in xenograft colorectal cancer.

Rumeysa Özyurt, Nilüfer Erkasap, Mete Özkurt

|Apr 07, 2023
Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer.

Rumeysa Ozyurt, Bulent Ozpolat

|Nov 11, 2022
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies.

Rumeysa Ozyurt, Bulent Ozpolat

|Jun 08, 2022
The Effects of Cannabinoid Agonist, Heat Shock Protein 90 and Nitric Oxide Synthase Inhibitors on Increasing IL-13 and IL-31 Levels in Chronic Pruritus.

Zeynep Gizem Todurga Seven, Ayse Çakır Gündoğdu, Rumeysa Ozyurt

|Aug 09, 2021
miR663 Prevents Epo Inhibition Caused by TNF-Alpha in Normoxia and Hypoxia.

Mete Ozkurt, Thomas Hellwig-Bürgel, Reinhard Depping

Pageof 2

Frequent Collaborators

3 joint publications

Mete Özkurt

3 joint publications

Nilüfer Erkasap

2 joint publications

Ayse Çakır Gündoğdu

1 joint publications

Muhammed Kandemir